EXTEND PIX301: a phase III randomized trial of pixantrone versus other chemotherapeutic agents as third-line monotherapy in patients with relapsed, aggressive non-Hodgkin's lymphoma / Engert A; Herbrecht R; Santoro A; Zinzani PL; Gorbatchevsky I.. - In: CLINICAL LYMPHOMA & MYELOMA. - ISSN 1557-9190. - STAMPA. - 7:(2006), pp. 152-154. [10.3816/CLM.2006.n.055]

EXTEND PIX301: a phase III randomized trial of pixantrone versus other chemotherapeutic agents as third-line monotherapy in patients with relapsed, aggressive non-Hodgkin's lymphoma.

ZINZANI, PIER LUIGI;
2006

2006
EXTEND PIX301: a phase III randomized trial of pixantrone versus other chemotherapeutic agents as third-line monotherapy in patients with relapsed, aggressive non-Hodgkin's lymphoma / Engert A; Herbrecht R; Santoro A; Zinzani PL; Gorbatchevsky I.. - In: CLINICAL LYMPHOMA & MYELOMA. - ISSN 1557-9190. - STAMPA. - 7:(2006), pp. 152-154. [10.3816/CLM.2006.n.055]
Engert A; Herbrecht R; Santoro A; Zinzani PL; Gorbatchevsky I.
File in questo prodotto:
Eventuali allegati, non sono esposti

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11585/33703
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 7
  • ???jsp.display-item.citation.isi??? 6
social impact